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1. Introduction  
The soybean seeds (Glycine max) originate from north-eastern Asian regions, especially 
China and Korea and, since its introduction to American colonies in 1765 (Hymowitz and 
Harlan 1983), its consumption has been worldwide spread. Soybeans are an economically 
important crop, which has been traditionally used for animal feed as well as for human 
food. In this field, soy has been a valuable resource for humankind by providing excellent 
proteins and other nutrients and, in many countries, soybeans and soy-based foods are 
considered as a staple food thanks to its low cost and high availability (Khetarpaul et al. 
2004). Presently, in the market, there are several soy-based products and ingredients such as 
soy sauce, tofu, soy protein, soy-based beverages and fermented foods, like miso, tempeh, 
natto, etc. Besides the excellent nutritional properties such as the high protein content and 
the presence of polyunsaturated fatty acids, as well as the absence of cholesterol and lactose; 
soy has demonstrated to provide a preventive effect in the occurrence and development of 
several common diseases.  
In the developed countries, the incidence and prevalence of illnesses like diabetes, 
osteoporosis, cancer, or cardiovascular diseases, among others, are becoming highly 
important and some of them constitute the leading causes of mortality. Generally, oxidative 
damage, inflammatory responses or lipid accumulation as well as other more complex 
biochemical processes are involved in the disease development mechanisms. Scientific 
studies have revealed that most of these illnesses are strongly related to genetic and/or 
environmental factors. In this field, the diet has shown to play an important role in 
preventing the appearance or even reducing the associated symptoms. The lower incidence 
of these diseases in eastern societies, where the soy consumption is considerably high, 
remarks the importance of diet and highlights the beneficial properties of soy. Many of the 
soy benefices have been attributed to the occurrence of several kinds of phytochemicals, 
such as isoflavones, soyasaponins, phytates, or protease inhibitors. These bioactive 
compounds seem to provide a preventive effect by means of reducing or even inhibiting the 
mechanisms of the disease development. Hence, some of their most important properties, 
for instance, the antioxidant, the antiinflammatory or the estrogenic activities, may be 
involved in the disease prevention.  
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In this chapter, the most important aspects of soy composition will be discussed in terms of 
nutritional profile and the occurrence of bioactive compounds. The influence of soy 
consumption on the disease prevention and the role that the phytochemicals play in the 
mechanisms of health promotion will be reviewed.  
2. Nutritional profile of soy  
Nowadays, there is a clear increase in the amounts of commercial soy-based foods so that 
the soy consumption has risen greatly. Some products are becoming increasingly popular 
and they are largely consumed by people in general, such as soy sauces and soy-based 
beverages. On the other hand, soy protein products are largely used as ingredients in meat 
products, breads, soups, and beverages, among others. New soy foods are continuously 
being developed and actually include cheese, salami, drinks and vegetarian meat 
substitutes. Traditionally, soy has been consumed either as fermented or as nonfermented 
foods (Wang and Murphy 1996; Umphress et al. 2005). The most common fermented soy-
based foods include tempeh, miso, natto, sufu, soy sauce, and douchi, whereas the 
nonfermented foods comprise fresh soybeans, soybean sprouts, soymilk, tofu, and protein 
enriched foods such as soy protein flours and/or grits, textured soy protein and soy protein 
concentrates or isolates. Nutrient composition can be influenced not only by the genetics, 
the cultivar, or the growth conditions, but also by the processing and refinement; therefore, 
significant variations can be detected in the soybeans and soy-based foods nutritional profile 
(Grieshop and Fahey 2001; Grieshop et al. 2003).  
Whole soy protein content usually ranges between 30 and 48% (Cai et al. 1997; Esteves et al. 
2010). Glycinin toghether with -, -, and -conglycinins are soybean globulins and they 
represent the major components of the storage proteins of soy seeds. The seeds also contain 
bioactive proteins, including ┙-amylase, cytochrome c, lectin, lipoxygenase, urease and 
protease inhibitors (Wolf 1970). Soy is rich in essential amino acids, like lysine, isoleucine 
and leucine; and also in other dispensable ones, such as glutamic and aspartic acids. 
Nevertheless, sulphur-amino acids (cysteine and especially methionine), tryptophan and 
valine are limiting amino acids in soy (Aletor 2010; Anuonye et al. 2010).  
Lipid content is considerably high in soy (17-25%) (Cai et al. 1997) although it is not usually 
a disadvantage because soy is generally used to produce edible oil and fat. Soy provides 
polyunsaturated fatty acids, being linoleic acid the most abundant, occurring between 42 
and 58%. Significant amounts of oleic (20-25%), palmitic (8-11%), linolenic (1-8%) and stearic 
(3-6%) acids are also found whereas fatty acids with higher carbon number (eicosanoic, 
eicosenoic, docosanoic and tetracosanoic acids) are only detected in trace amounts (0.1-0.5%) 
(Vieira et al. 1999; Yuan and Chang 2007). 
Carbohydrates constitute approximately the 30-35% of the whole soy seed, especially 
polysaccharide and dietary fibre. Starch, hemicelluloses, cellulose, stachylose, sucrose, 
raffinose, arabinose and glucose are included in its carbohydrate fraction. Dietary fibre, as 
non-starch polysaccharides, is mainly found in the hulls and the content range between 9 
and 16% of whole soy seed (Esteves et al. 2010). The insoluble fraction is the predominant, 
comprising approximately 74-78%. It is mainly composed of arabinose, galactose, glucose, 
xylose and uronic acids. Soluble fibre ranges from 22 to 26% and the principal monomers 
are arabinose, galactose and uronic acids (Redondo-Cuenca et al. 2006).  
Among the nutritionally important major minerals (table 1), whole soy shows high contents of 
potassium, phosphorous, calcium, magnesium and sodium (Vieira et al. 1999; Aletor 2010).   
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 K P Ca Mg Na 
Soy content 
(mg/100 g DW) 
1600-1900 450-650 170-320 215-270 10-21 
Table 1. Major minerals present in soy (DW: dried weight). 
Furthermore, other trace minerals are also found (table 2), for instance, iron, zinc, 
manganese, cooper and selenium, nickel and chromium (Anuonye et al. 2010).  
 
 Fe Zn Mn Cu Se Ni Cr 
Soy content 
(mg/100 g DW) 
13-19 3-5 2-3 ~2 ~2 ~1 ~1 
Table 2. Minor minerals detected in soy (DW: dried weight). 
Soy contains water soluble vitamins (table 3), such as ascorbic acid (vitamin C) whose 
content varies from 0.03 to 35 mg/100 g dried weight, riboflavin (B2) from 0.7 to 0.9 mg/100 
g dried weight and B6, which is the most abundant (2-5.5 mg/100 g dried weight) (Anuonye 
et al. 2010). Vitamin E, a lipid soluble vitamin is also detected in soy; thus, four kinds of 
tocopherol compounds are found in soy: ┙-tocopherol, whose content varies from 0.4 to 8 
mg/100 g dried weight; ┛-tocopherol, from 4 to 80 mg/100 g dried weight; ├-tocopherol, 
from 1 to 50 mg/100 g dried weight; and a trace amount of ┚-tocopherol (Kasim et al. 2010; 
Li et al. 2010). 
 
 Vit. C Vit. B2 Vit. B6 ┙-Toc. ┛-Toc. ├-Toc. ┚-Toc. 
Soy content 
(mg/100 g DW)
0.03-35 0.7-0.9 2-5.5 0.4-8 4-80 1-50 traces 
Table 3. Vitamins found in soy (DW: dried weight). 
3. Bioactive compounds occurring in soy 
Soy is a source not only of proteins, vitamins and minerals, but also of many bioactive 
compounds, such as isoflavones, protease inhibitors, saponins, and phytates. Substantial 
changes of phytochemical content in soybean seeds are found depending on the source 
because, as well as the nutritional profile, the functional composition is strongly affected by 
genetic and environmental factors, together with the processing conditions. The great 
importance of these compounds is based on their biochemical activity which results in 
health promotion and disease prevention. The activity of phytochemicals in the human body 
may be strongly influenced by absorption and bioavailability. Thus, relative disposition 
appears to be determined by the chemical nature, in terms of solubility and susceptibility to 
degradation by gut microorganisms. 
3.1 Isoflavones 
Soy has attracted much attention due to its healthy benefits associated with the presence of 
isoflavones. They comprise a group of naturally occurring flavonoids, which are 
heterocyclic phenols, possessing three aromatic rings with several hydroxyl groups. Soy 
contains three main types of isoflavones occurring in different chemical forms, which are the 
aglycones (daidzein, genistein and glycitein), the ┚-glucosides (daidzin, genistin and 
glycitin), the 6”-O-acetyl-┚-glucosides and 6”-O-malonyl-┚-glucosides. Furthermore, the 4’-
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methyl ethers of daidzein and genistein, formononetin and biochanin A, are also detected in 
soy (figure 1).  
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Fig. 1. Chemical structure of the main isoflavones occurring in soy.  
Total isoflavone content in whole soy usually ranges from 50 to 450 mg/100 g dried weight 
(Kim et al. 2005). Generally, the ┚-glucosides account for the 30-35%, the 6”-O-malonyl-┚-
glucosides are the most abundant (50-65%), the aglycone content is less important (4-12%) 
and the 6”-O-acetyl-┚-glucosides are usually scarce (0-5%) (Franke et al. 1999; Genovese et 
al. 2006). These percentages may change significantly when soy is processed since the 6”-O-
malonyl-┚-glucosides are instable under heat so that they are converted into the 
corresponding aglycones (Villares et al. 2011). Daizein, genistein and their derivatives are 
commonly the most abundant isoflavones in soy whereas glycitein is sometimes only 
detected as traces. About 80-90% of total seed isoflavones are located in the cotyledons 
(Tsukamoto et al. 1995).  
Isoflavones have attracted a great deal of attention due to their antioxidant (Kao and Chen 
2006; Chung et al. 2008), antiinflammatory (Park et al. 2007; García-Lafuente et al. 2009), and 
antiallergic (Chang et al. 2000) properties. These compounds have shown to reduce the risk 
of cardiovascular disease (Jackman et al. 2007), and promote the inhibition of cancer cell 
growth (Sarkar and Li 2003; Kao et al. 2007; Davis et al. 2008). Furthermore, soy intake plays 
an important role in the prevention of several ailments including osteoporosis, and 
menopausal symptoms (Dijsselbloem et al. 2004; Phrakonkham et al. 2007; Coxam 2008; Ma 
et al. 2008) since the isoflavones act as antiestrogens (Okamoto et al. 2006; Zhang et al. 2007) 
and tyrosine protein kinase inhibitors (Papazisis et al. 2006).  
3.2 Lectins and trypsin inhibitors 
Lectin (hemagglutinin or agglutinin) is a highly specific carbohydrate-binding protein, with 
the highest affinity for N-acetyl-D-galactosamine, and an important role in biological 
recognition. Soybeans seeds contain between 300 and 600 mg/100 g of lectins (Gu et al. 
2010), which is approximately 0.2 – 1% of the soy protein (Rizzi et al. 2003; Anta et al. 2010). 
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Trypsin inhibitors comprise several protein and peptides including the Bowman-Birk 
inhibitors, the Kunitz inhibitors and lunasin. Soybean Bowman-Birk inhibitor (BBI) is a 
polypeptide of 71 amino acids belonging to the serine-protease inhibitor family. BBI tighyly 
interacts with trypsin or chymotrypsin and strongly inhibits their enzymatic activities 
(Odani and Ikenaka 1972). The Kunitz soybean inhibitor has been widely studied and 
consists of a single polypeptide chain crosslinked by two disulfide bridges, which inhibits 
trypsin and, in a lesser extent, chymotrypsin. Lunasin is a 43 amino acid peptide originally 
isolated from soy (De Mejia et al. 2004). Trypsin inhibitors usually range from 3000 to 6000 
mg/100 g of soy seed (Gu et al. 2010), which comprise between 30 and 125 mg per gram of 
protein (Esteves et al. 2010). 
Lectins and protease inhibitors have been usually considered as antinutrients because they 
may reduce the nutritional value of soybean (Machado et al. 2008; Ma and Wang 2010). 
Nevertheless, their intake have shown preventing properties against several diseases, for 
instance cancer (de Lumen 2005). Soy proteins seem to reduce the total lipids and cholesterol 
levels in the liver of rats (Potter 1995; Nagaoka et al. 1999). The Bowman-Birk soybean 
inhibitor has demonstrated to be involved in antiinflammatory processes preventing the 
development of cancer and coronary diseases (Dia et al. 2008). Furthermore, other peptides 
from soy have shown antihypertensive properties in spontaneously hypertensive rats (Chen 
et al. 2004; Gouda et al. 2006).   
3.3 Saponins 
Saponins are triterpenes or steroid aglycones with one or more sugar chains. The chemical 
structure comprises a hydrophobic nucleus (sapogenin) to which hydrophilic sugar chains 
are bound (Guclu-Ustundag and Mazza 2007). Saponins from soy, usually referred as 
soyasaponins, are classified in A, B and E groups depending on the chemical structure of the 
aglycones (Shiraiwa et al. 1991). Group A saponins have a hydroxyl group at the C-21 
position whereas group B saponins have a hydrogen atom at the same position. Group E 
saponins are considered the oxidation products from group B saponins and differ from 
groups A and B by having a carbonyl group at C-22. In figure 2 the chemical structure of 
main soyasaponins is depicted.  
Soy is the primary dietary source of saponins, which are generally in the hypocotyl, and the 
three groups of soyasaponins occur. The total content in soy may vary from 140 to 975 
mg/100 g dried weight (Tsukamoto et al. 1995) and the group B usually accounts for up to 
70% of total soyasaponins (Paucar-Menacho et al. 2010), being the subgroups I, ┙g, ┚g and 
┛g the most abundant. In the contrary, the saponins II, III, IV, V and ┛a are found in low 
amounts (Hubert et al. 2005). The group A soy saponins comprises several species 
depending on the sugar composition and the position to be attached the sugar moiety, 
generally the C-3 although sometimes the C-22 position of the aglycones. Among them, 
subgroup Aa is the most abundant (Paucar-Menacho et al. 2010).   
The group A soyasaponins are associated with the undesirable bitter and astringent taste of 
soy; nevertheless, the group B and E saponins and their labile precursor 2,3-dihydro-2,5-
dihydroxy-6-methyl-4H-pyran-4-one – conjugated saponin (DDMP) have shown several 
health benefits. Thanks to their amphiphilic nature, saponins have been added to 
pharmaceutical preparations the enhance absorption of bioactive compounds or drugs. In 
addition, they have been employed as immunological adjuvants in vaccine formulations due 
to their immune enhancing properties (Kensil et al. 2004). For instance, saponins appear to 
inhibit the infectivity of the AIDS virus (Nakashima et al. 1989; Vlietinck et al. 1998) and the 
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Fig. 2. Chemical structure of the saponins occurring in soy.  
herpes simplex virus type 1 (Hayashi et al. 1997). Soyasaponins are reported to be 
hepatoprotective (Kinjo et al. 2003) and have also shown a preventive effect on the growth 
of human colon cancer cells (Tsai et al. 2010). The chemical structure significantly influences 
the saponins bioactivity; thus, individual soyasaponin I exhibits lipid peroxidation 
inhibitory effects in vitro, antiinflammatory properties in mice with TNBS-induced colitis 
(Lee et al. 2010), and potentially reduces metastatic ability of cancer cells (Chang et al. 2006). 
Moreover, soyasaponins I and III are reported to induce apoptosis in cells involved in 
hepatocarcinoma (Zhang and Popovich 2010).  
3.4 Phytates 
Phytic acid (myo-inositol-1,2,3,4,5,6-hexakis dihydrogen phosphate, figure 3) is the main 
storage source of phosphorus and minerals in many plant tissues. Besides phytate (the salt 
of phytic acid), other inositol phosphates, such as inositol pentaphosphates and inositol 
tetraphosphates, exist although to a much lower extent (Schlemmer et al. 2009). Phytic acid 
is found in many seeds and soy content varies from 1 to 3% (Esteves et al. 2010).Phytates 
have been traditionally regarded as antinutrients because they form complexes with 
proteins and minerals resulting in enzyme inhibition and mineral deficiencies. 
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Fig. 3. Chemical structure of myo-inositol-1,2,3,4,5,6-hexakis dihydrogen phosphate.  
Nevertheless, phytates intake has shown beneficial properties, for instance, blood glucose 
levels, serum total cholesterol and LDL cholesterol are significantly reduced after their 
intake (Lee et al. 2006; Lee et al. 2007). Furthermore, their consumption demonstrated to 
increase bone mineral density, thus, preventing osteopororis (Lopez-Gonzalez et al. 2008). 
Phytates also inhibit the crystallisation of calcium salts (oxalates and phosphates) avoiding 
the formation of kidney stones (Grases et al. 2000). The chelating effect of phytates avoids 
the excess iron accumulation and, therefore, provides a protective effect in Parkinson’s 
disease (Xu et al. 2008) and antioxidant properties by inhibiting the Fenton oxidative 
reaction and the iron mediated lipid peroxidation (Graf and Eaton 1990; Rimbach and 
Pallauf 1998). On the other hand, phytate play an important role in cancer prevention and 
control of experimental tumor growth, progression and metastasis. Phytate appear to reduce 
cell proliferation and also induces differentiation of malignant cells. Hence, phytate has 
shown to decrease cancer biomarkers of colon, liver, lung, prostate, breast, skin and soft 
tissue carcinogenesis in rats and/or mice (Jenab and Thompson 1998; Jenab and Thompson 
2000; Shamsuddin 2002; Vucenik and Shamsuddin 2004). Furthermore, the parent 
compound inositol appears to enhance the anticancer effect of conventional chemotherapy 
in addition to control cancer metastasis and improve quality of life (Vucenik and 
Shamsuddin 2006). Thus, the combination of phytate plus inositol holds great promise in 
cancer treatments (Vucenik and Shamsuddin 2003; Singh and Agarwal 2005).  
4. Disease prevention 
In table 4, the most important effects of the bioactive compounds occurring in soy linked to 
the main mechanisms related to common diseases prevention are shown.  
In addition to the excellent nutritional properties of soy, the occurrence of natural 
phytochemicals showing a number of health protective effects has triggered the soy 
consumption. Presently, soybeans and soy-based foods are consumed worldwide and they 
can be considered as good candidates to be included in a healthy diet. Soy intake has been 
related to the prevention of several diseases, for instance, cancer, Alzheimer, osteoporosis, 
or coronary heart diseases.  
Most of the health benefits of soy have been associated with the occurrence of isoflavones; 
nevertheless, as commented in the previous section, other phytochemicals also play an 
important role in the disease prevention. The studies have been performed not only by 
evaluating the soy intake but also the effect of supplementation with the isolated bioactive 
compounds. Generally, the observed effects are dose-dependent so as to show a preventive 
or the opposite activity deppending on the concentration.  
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Disease Compound Main effects 
Cardiovascular 
disease 
Isoflavones 
Reduction of total lipids and triglycerides 
Inhibition of oxidative stress 
Decrease in bood pressure 
Inhibition of NO and TNF-┙ 
Phytate 
Reduction of total homocysteine, transferrin 
saturation, and ferritin 
Saponins 
Hypocholesterolemic properties 
Reduction of elevated blood sugar 
Inhibition of lipid peroxidation 
Soy proteins 
Total cholesterol and lipids reduction 
Antihypertensive properties 
Cancer 
Isoflavones 
Reduction of oxidative damage 
Inhibition of cancer cell proliferation 
Activity in estrogen and progesterone receptors 
Inhibiton of protein tyrosine kinases 
Cessation of DNA, RNA, and protein synthesis of 
the carcinogenic cells 
Induction of apoptosis 
Trysin inhibitors 
Suppression of cancer cell invasion 
Reduction of tumor generation and cell proliferation 
Inhibition of tumor promotion by avoiding the 
digestion of proteins 
Reduction of carcinogens adsorption 
Saponins 
Suppression of the inflammatory response 
Induction of apoptosis 
Antiestrogenic activity 
Inhibition of tumor cell metastasis 
Antimutagenic activity effect 
Bile acid binding action 
Normalization of carcinogen-induced cell 
proliferation 
Osteoporosis 
Isoflavones (Effects have not reached a consensus) 
Phytate Reduction of bone mineral density loss 
Alzheimer Isoflavones 
Inhibition of amyloid-┚-peptide fibril formation 
Suppression of the inflammatory response 
Reduction of oxidative damage 
Table 4. Main mechanisms of action observed for the bioactive compounds present in soy 
related to disease prevention. 
4.1 Cardiovascular disease 
Cardiovascular diseases (CVD) remain the largest cause of death in developing countries. 
Coronary heart disease (CHD) and cerebrovascular disease, which includes stroke and 
transient ischemic attacks, are the main CVD incidents. Coronary heart disease is 
significantly more frequent than stroke, and increases considerably after menopause as a 
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consequence of higher levels of low density lipoproteins (LDL) and total cholesterol (Rosano 
et al. 2007). Cardiovascular diseases have a multifactorial aetiology and the pathogenesis of 
arterial forms of CVD is associated with atherosclerosis, an inflammatory process that 
develops at specific locations within the arterial tree. Potential risk biomarkers have been 
identified, such as lipid and lipoprotein metabolism (LDL and HDL cholesterol and 
triacylglycerol amounts), the haemostatic function, the oxidative damage, the homocysteine 
metabolism, and blood pressure (Mensink et al. 2003). The relationship between the 
biomarker and the risk has not clearly reached a consensus; hence, only LDL and HDL 
cholesterol, triacylglycerol, homocysteine and blood pressure are well-validated and 
generally accepted biomarkers.  
Asiatic populations, whose diet is particularly rich in soy, show low rates of CVD, whereas 
groups moved to western societies lose this protection (Nagata 2000; Zhang et al. 2003). This 
fact highlights the cardiovascular disease protection by the occurring phytochemicals in soy, 
specially isoflavones and other flavonoid derivatives. Epidemiological studies clearly 
evidence that isoflavones and soy bioactive proteins are involved in CVD prevention (Cano 
et al. 2010; Jenkins et al. 2010); thus, they have demonstrated to reduce total cholesterol, 
triglycerides and LDL. A possible mechanism could involve the modulation of LDL receptor 
levels in human liver (Carroll and Kurowska 1995). Furthermore, dietary supplementation 
with soy isoflavones favorably alters insulin resistance and controls glycemic levels 
(Jayagopal et al. 2002). Recent studies have demonstrated that daily ingestion of purified soy 
isoflavones or soy-based foods significantly decreases blood pressure in adults (Matsui et al. 
2010; Taku et al. 2010). On the other hand, individual isoflavones appear to play an 
important role in other biochemical processes related to CVD, for instance, genistein and 
daidzein seem to inhibit the nitric oxide (NO) and tumour necrosis factor alpha (TNF-alpha) 
production, showing genistein a greater inhibitory effect (Gottstein et al. 2003). Regarding to 
hemostasis, there is still uncertainty about their role in the hemostatic equilibrium; to date, 
these phytochemicals are involved in platelet aggregation mechanisms, including the 
blockage of the calcium channels (Dobrydneva et al. 2002) or the thromboxane A2 receptor 
(Muñoz et al. 2009), the reduction in the density of thromboxane A2 receptors (Garrido et al. 
2006), or the interference with different platelet singnalling pathways triggered by thrombin 
(Navarro-Nuñez et al. 2009). On the other hand, phytates have been also evaluated in terms 
of protecting against CVD risks in postmenopausal women. Combined with soy protein, 
they have shown a potential atherosclerotic prevention because of the reduction of total 
homocysteine, transferrin saturation, and ferritin (Hanson et al. 2006). Furthermore, other 
biochemicals found in soy are also involved in CVD prevention, for instance, soyasaponins 
show hypocholesterolemic properties because they can form insoluble complexes with 
cholesterol so as to inhibit the intestinal absorption, and saponins could interfere with the 
enterohepatic circulation of bile acids by forming mixed micelles, which are blocked to be 
reabsorbed by the terminal ileum (Oakenfull and Sidhu 1990). Soyasaponins also reduce 
blood sugar when it is elevated and lipid peroxidation levels. In addition, soy proteins have 
shown an overall total cholesterol reduction in postmenopausal women (Mackey et al. 2000) 
as well as other peptides from soy have shown antihypertensive properties (Chen et al. 2004; 
Gouda et al. 2006). 
The similar activities observed for the different bioactive compounds occurring in soy may 
indicate that the disease prevention could be achieved by the same or very similar 
mechanism. In a soy-based diet, the intake of different types of phytochemicals may favour 
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the synergistical interaction so as to induce preventive effects in cardiovascular disease that 
could not be observed with isolated pure compounds.  
4.2 Cancer 
Cancer is a leading cause of death worldwide. Prostate, breast, lung and colon cancers are 
the most common, being breast in women and prostate cancer in men the most prevalent. 
Despite genetic factors, diet may prevent against cancer appearance and development. In 
this field, soy-based foods are known to be inversely associated with the cancer risk. The 
strongest protective effect of the soy intake was reported for breast, prostate, and colon 
cancers (Adlercreutz et al. 1995; Wang and Kurzer 1997). The occurring phytochemicals, 
including isoflavones, phytates, saponins, and protease inhibitors, are believed to contribute 
to the biological effects observed after soy consumption (Messina et al. 1994).  
The cancer protective properties of isoflavones may be attributed to their antioxidant 
(Ibrahim et al. 2008), and antiestrogenic (Cederroth and Nef 2009) actions, or their 
antimutagenic and antiproliferative activities by means of different mechanisms, such as the 
inhibition of protein tyrosine kinases or via cessation of DNA, RNA, and/or protein 
synthesis of the carcinogenic cells (Hirano et al. 1994; Kurzer and Xu 1997). Furthermore, 
isoflavones from soy show the ability of inhibiting the transformation, the differentiation 
(Constantinou and Huberman 1995), and the angiogenesis (Fotsis et al. 1995) of the 
carcinogenic cells, together with the induction of apoptosis (Kyle et al. 1997). Meta-analysis 
of epidemiological studies shows that soy isoflavones consumption contributes to reduce 
the risk of breast cancer incidence; hence, the protective effect of soy was only observed 
among studies conducted in Asian but not in Western populations (Dong and Qin 2011). 
The preventive effect is significantly important in post-menopausal women, according to the 
estrogenic activity of isoflavones, which is commonly associated to the anticarcinogenic 
mechanism of protection (Kang et al. 2010). Similarly, soy isoflavones have shown a 
preventive effect in prostate cancer (Severson et al. 1989; Kucuk 2010). In addition, a meta-
analysis performed for Japanese and Korean populations demonstrated that consumption of 
non-fermented rather than fermented soy-based foods may reduce gastric cancer risk (Kim 
et al. 2011). On the other hand, soy protein fractions also play an important role in cancer 
prevention. Protease inhibitors may act as anticarcinogenic agents by means of different 
mechanisms, including the suppression of reactive oxygen species (superoxide anion free 
radicals) formation by stimulated neutrophils; inhibition of tumor promotion; growing 
cancer cells deprivation of essential amino acids by avoiding the digestion of proteins; and 
the adsorption of carcinogens during passage through the digestive tract, by acting as an 
insoluble fibre (Friedman and Brandon 2001). In this field, a Kunitz type trypsin inhibitor 
isolated from Korean large black soybeans appeared to exert antiproliferative activity 
toward CNE-2 and HNE-2 nasopharyngeal cancer cells, MCF-7 breast cancer cells, and Hep 
G2 hepatoma cells (Fang et al. 2010). The Kunitz type protease inhibitor, bikunin, has shown 
to suppress cancer cell invasion in vitro and metastasis in vivo (Kobayashi et al. 2004). 
Finally, lunasin seems to reduce tumor generation and cell proliferation in breast tumor 
sections (Hsieh et al. 2010). Other bioactive compounds occurring in soy, such as saponins, 
have shown anticarcinogenic properties in colon, liver or breast cancer cell lines. The 
proposed mechanisms of action include direct cytotoxicity, induction of apoptosis, 
antiestrogenic activity, inhibition of tumor cell metastasis, antimutagenic activity effect, bile 
acid binding action, and normalization of carcinogen-induced cell proliferation (Rao and 
Sung 1995). Group B saponins seem to reduce colon cancer cell proliferation possibly by 
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suppressing the inflammatory responses (Kim et al. 2004; Ellington et al. 2005). Thus, 
soyasaponin-supplemented diets could reduce the incidence of aberrant crypt foci, which 
suggest that they may play an important role in the incidence of colon cancer (Koratkar and 
Rao 1997).  
4.3 Osteoporosis 
Estrogen deficiency is involved in many of the proposed mechanisms taking place during 
the development of several menopausal-associated diseases, such as osteoporosis, breast 
cancer, and cardiovascular diseases. Primary type 1 or postmenopausal osteoporosis is a 
reduction of the bone mineral density (BMD) resulting in a significant risk factor for 
fracture, generally in vertebrae, forearm and hip. Soy has been evaluated as a protective 
agent against BMD loss due to the widely recognised estrogenic activity of isoflavones. 
Isoflavones can be considered as possible selective estrogen receptor modulators, which 
may bind to estrogen receptors and selectively stimulate or inhibit estrogen-like action 
(Setchell 2001). The preventive estrogenic activity could act by means of different 
mechanisms, for instance, the direct modulation of osteoblast and osteoclast activity; the 
regulation of the resorptive effects of parathyroid hormone; the inhibition of tyrosine-kinase 
activity with subsequent changes in the activity of alkaline phosphatase; or the inhibition of 
interleukin-1 release, a potent bone resorption agent (Bitto et al. 2010; Pilsakova et al. 2010).  
Studies with animals have proved that soy isoflavones may prevent bone density loss. 
Protection effects may be significantly modified by the addition of prebiotic 
fructooligosaccharides, which increase the isoflavone bioavailability. Therefore, a genistin-
rich diet combined with the intake of fructooligosaccharides is capable of preventing loss of 
bone mineral density by increasing whole-body, right femur, and fourth lumbar bone 
mineral density in rats (Hooshmand et al. 2010). Similarly, the addition vitamins D and K 
and calcium enrichment may enhance the isoflavone preventive effects in bone mass (Jeon et 
al. 2009). Nevertheless, published studies with humans are inconsistent and do not clearly 
support soy protective effect against bone loss. Some of the meta-analysis including data 
from more than 1000 menopausal women revealed that daily ingestion of soy isoflavones 
may increase lumbar spine BMD whereas no significant effects are shown in femoral neck, 
hip, and trochanter BMD (Taku et al. 2010). In contrast, epidemiological studies did not 
found a clear relationship between soy intake and prevention of bone loss and consequently 
fractures in perimenopausal and postmenopausal Western women (Lagari and Levis 2010; 
Ricci et al. 2010). One of the potential inconsistencies among the epidemiological studies 
could be the differences in the isoflavone metabolism. In this field, equol has shown 
stronger estrogenic activity than the parent compound daidzein (Ishimi 2009). Other authors 
propose that the phytate intake associated to a soy-rich diet could provide protection 
against osteoporosis since phytates may reduce BMD loss (Lopez-Gonzalez et al. 2008).  
4.4 Alzheimer’s disease 
The neurodegenerative pathology Alzheimer’s disease is the most common form of 
dementia among people above 65 years old (Hendrie 1998), being more common in women 
regarding to men (Vina and Lloret 2010).  
Neuronal dysfunction, eventually leading to dementia, is caused by accumulation of 
filamentous proteins, such as the amyloid-┚ peptide, which provokes reactive oxygen 
species (ROS) generation, increase in Ca2+ levels and other cytotoxic stimuli. Estrogenic 
compounds protect cells against mitochondrial toxicity of amyloid-┚ peptide toxicity; hence, 
soy isoflavones have demonstrated to prevent Alzheimer’s disease by inhibiting the 
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amyloid-┚ peptide fibril formation in vitro. Among the isoflavones tested, the aglycones and 
equol (a metabolite from daidzein) caused the greater inhibition (up to 30%) (Henry-Vitrac 
et al. 2010). On the other hand, soy isoflavones prevent the occurrence of Alzheimer’s 
disease because of the antiinflammatory and antioxidant properties (Hsieh et al. 2009).  
4.5 Other beneficial effects 
In addition to the described diseases prevention, numerous other benefits are reported to be 
associated with soy-containing diets. For instance, as commented before, soy seems to 
provide protective effects against obesity by lowering the LDL and total cholesterol levels; 
and diabetes by reducing the glucose concentration. Furthermore, soybean inhibitors may 
protect against induced pancreatitis (Jurkowska et al. 1992), gastrointestinal mucosal injury 
(Funk and Baker 1991), and kidney diseases (Kinjo et al. 1998). Soyasaponins show 
significant inhibitory effects on the prevalence of herpes labialis and inhibit the replication 
of human cytomegalovirus and influenza virus (Hayashi et al. 1997).  
5. Conclusion 
Soy and soy-based foods have demonstrated to be good candidates to be included in healthy 
diets. Soy seeds provide high amounts of protein, dietary fibre, polyunsaturated fatty acids, 
vitamins and minerals whereas cholesterol and lactose levels are considerably low. Soy has 
attracted much interest not only because of its excellent nutritional properties, but also due 
to the occurrence of a number of bioactive compounds, such as isoflavones, saponins, 
protease inhibitors or phytates, among others. Many of the healthy benefits attributed to soy 
intake are due to the high content of these phytochemicals. Disease prevention comprises a 
wide range of mechanisms of action and some of these bioactive compounds have shown to 
be involved not only in a unique reaction but in some of them. Among the most important 
properties, the bioactive compounds exert antioxidant, antiinflammatory, or estrogenic 
activities, which have been demonstrated to be implicated in the health promotion and 
disease prevention. Concluding, according to the epidemiological studies, soy may provide 
a protective effect against common diseases, for instance, cancer, cardiovascular disease, 
osteoporosis or even Alzehimer’s disease. 
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